Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | SLC13A5 | Q86YT5 | 4/20 | 0.48 |
| ▸ | LMNA | P02545 | 5/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.44 |
| ▸ | TP53 | P04637 | 2/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | GMNN | O75496 | 1/20 | 0.44 |
| ▸ | ESR1 | P03372 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10397330 | 0.98 | ALDH1A1 (0.47) | ALDH1A1SLC13A5LMNAKDM4EKMT2A | |
| SCHEMBL8642720 | 0.93 | SLC13A5 (0.43) | ALDH1A1SLC13A5LMNAKDM4EKMT2A | |
| SCHEMBL2307577 | 0.89 | ALDH1A1 (0.47) | ALDH1A1SLC13A5LMNAKDM4EKMT2A | |
| SCHEMBL2852481 | 0.88 | ALDH1A1 (0.46) | ALDH1A1SLC13A5LMNAKDM4EKMT2A | |
| SCHEMBL28185581 | 0.88 | MAPK1 (0.40) | ALDH1A1SLC13A5LMNAKDM4EKMT2A | |
| SCHEMBL28687971 | 0.88 | ALDH1A1 (0.46) | ALDH1A1SLC13A5LMNAKDM4EKMT2A | |
| SCHEMBL28185666 | 0.88 | TSHR (0.49) | ALDH1A1LMNAKDM4EKMT2ACYP1A2 | |
| SCHEMBL21296994 | 0.87 | ALDH1A1 (0.48) | ALDH1A1SLC13A5LMNAKDM4EKMT2A | |
| SCHEMBL28670693 | 0.86 | ALDH1A1 (0.44) | ALDH1A1SLC13A5LMNAKDM4EKMT2A | |
| SCHEMBL28676230 | 0.86 | ALDH1A1 (0.44) | ALDH1A1SLC13A5LMNAKDM4EKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230324802-A1 | RESIST UNDERLAYER FILM-FORMING COMPOSITION CONTAINING INDOLOCARBAZOLE NOVOLAK RESIN | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2023-10-12 | — | — | US | disclosed |
| US-11720024-B2 | Resist underlayer film-forming composition containing indolocarbazole novolak resin | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2023-08-08 | — | — | US | disclosed |
| US-20220404707-A1 | RESIST UNDERLAYER FILM-FORMING COMPOSITION CONTAINING INDOLOCARBAZOLE NOVOLAK RESIN | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2022-12-22 | — | — | US | disclosed |
| EP-4017476-A1 | PHARMACEUTICAL FORMULATIONS OF TENOFOVIR ALAFENAMIDE | GILEAD SCIENCES, INC. (US) | 2022-06-29 | — | — | EP | disclosed |
| CN-107417819-B | Solid catalyst component for olefin polymerization, catalyst and application thereof | 北京利和知信科技有限公司 | 2021-11-16 | — | — | CN | disclosed |
| CN-109280112-B | Catalyst composition suitable for propylene homopolymerization or copolymerization | 任丘市利和科技发展有限公司 | 2021-06-08 | — | — | CN | disclosed |
| WO-2021034804-A1 | PHARMACEUTICAL FORMULATIONS OF TENOFOVIR ALAFENAMIDE | GILEAD SCIENCES, INC. (US) | 2021-02-25 | — | — | WO | disclosed |
| CN-105267145-B | The self-emulsifying formulation of diphosphonate and related dosage form | 袁旭东 | 2019-06-21 | — | — | CN | disclosed |
| US-20180356732-A1 | RESIST UNDERLAYER FILM-FORMING COMPOSITION CONTAINING INDOLOCARBAZOLE NOVOLAK RESIN | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2018-12-13 | — | — | US | disclosed |
| CN-105973863-B | A kind of method of room temperature phosphorimetry detection benzoic acid | 齐齐哈尔大学 | 2018-08-14 | — | — | CN | disclosed |
| CN-1782752-A | Retardation film, and polarizing plate and display device using the same | KONICA MINOLTA OPTO INC (JP) | 2006-06-07 | — | — | CN | disclosed |
| EP-1102597-A1 | MULTIVALENT AGONISTS, PARTIAL AGONISTS, INVERSE AGONISTS AND ANTAGONISTS OF THE 5HT 4 RECEPTORS | Advanced Medicine, Inc. (US) | 2001-05-30 | — | — | EP | disclosed |
| WO-1999064055-A1 | MULTIVALENT AGONISTS, PARTIAL AGONISTS, INVERSE AGONISTS AND ANTAGONISTS OF THE 5HT4 RECEPTORS | ADVANCED MEDICINE, INC. (US) | 1999-12-16 | — | — | WO | disclosed |
| EP-0954596-A1 | ENHANCED PRODUCTION OF TAXANES BY CELL CULTURES OF $i(TAXUS) SPECIES | PHYTON, INC. (US) | 1999-11-10 | — | — | EP | disclosed |
| WO-1997044476-A1 | ENHANCED PRODUCTION OF TAXANES BY CELL CULTURES OF TAXUS SPECIES | PHYTON, INC. (US) | 1997-11-27 | — | — | WO | disclosed |
| WO-1997034580-A1 | SUPPOSITORY COMPOSITION OF THE DRUG WHICH HAS GASTRO-INTESTINAL DISTURBANCES OR UNDERGOES THE DECOMPOSITION BY GASTRIC ACID | DONG WHA PHARMACEUTICAL INDUSTRIAL CO., LTD. (KR) | 1997-09-25 | — | — | WO | disclosed |
| WO-1997030693-A1 | SUPPOSITORY COMPOSITION OF THE DRUG WHICH UNDERGO THE HEPATIC FIRST-PASS EFFECT | DONG WHA PHARMACEUTICAL INDUSTRIAL CO., LTD. (KR) | 1997-08-28 | — | — | WO | disclosed |
| US-4859687-A | Substituted 1,3-dioxolane compounds and their use as fungicides | CIBA-GIEGY CORPORATION (US) | 1989-08-22 | — | — | US | disclosed |
| EP-0109255-A2 | Glycerol derivatives | ONO PHARMACEUTICAL CO., LTD. (JP) | 1984-05-23 | — | — | EP | disclosed |
| US-4002586-A | FROM A SULFIDE, AN ACID, AND AN EPOXIDE COPOLYMER, SULFONIUM GROUPS BOUND ON SURFACE | THE DOW CHEMICAL COMPANY (US) | 1977-01-11 | — | — | US | disclosed |